首页 | 本学科首页   官方微博 | 高级检索  
     

LAG-3的免疫学功能及其抗体药物的研究进展
引用本文:田宝俊,于红阳,徐明波,曹荣月,杨仲璠. LAG-3的免疫学功能及其抗体药物的研究进展[J]. 中国细胞生物学学报, 2021, 0(2): 484-492
作者姓名:田宝俊  于红阳  徐明波  曹荣月  杨仲璠
作者单位:中国药科大学生命科学与技术学院;北京双鹭药业股份有限公司
摘    要:淋巴细胞活化因子-3(lymphocyte activation gene-3,LAG-3)又名CD223,为一类免疫检查点受体蛋白,主要表达于活化的免疫细胞中.LAG-3分子在生理条件下可维持机体免疫稳态,在肿瘤微环境中可介导肿瘤细胞的免疫逃逸,因此,可将LAG-3作为肿瘤免疫治疗的新靶点进行研究.LAG-3阻断性抗...

关 键 词:LAG-3  免疫逃逸  LAG-3抗体  肿瘤免疫治疗  抗体药物联用

Advances in the Research of the Immunological Function of LAG-3 and Its Antibody Drugs
TIAN Baojun,YU Hongyang,XU Mingbo,CAO Rongyue,YANG Zhong. Advances in the Research of the Immunological Function of LAG-3 and Its Antibody Drugs[J]. Chinese Journal of Cell Biology, 2021, 0(2): 484-492
Authors:TIAN Baojun  YU Hongyang  XU Mingbo  CAO Rongyue  YANG Zhong
Affiliation:(School of Life Science and Technology,China Pharmaceutical University,Nanjing 210009,China;Beijing Shuanglu Pharmaceutical Co.,Ltd.,Beijing Engineering Research Center for Recombinant Proteins and Long-Acting Preparations,Beijing 100143,China)
Abstract:LAG-3(lymphocyte activation gene-3),also known as CD223,is a type of immune checkpoint receptor protein,which is primarily expressed in activated immune cells.LAG-3 can maintain immune homeostasis under physiological conditions and mediate the immune escape of tumor cells in the TME(tumor microenvironment).Therefore,LAG-3 can be used as a new target for tumor immunotherapy.LAG-3 blocking antibody can effectively relieve the tolerance caused by other immune checkpoint inhibitors,and has a better clinical effect in drug combination.At present,many LAG-3-related antibody drugs are in the development stage,some of which have entered the clinical stage.This paper systematically reviews the structure,expression,and function of LAG-3,as well as elaborates the clinical research progress and market situation of LAG-3-related antibody drugs.
Keywords:LAG-3  immune escape  LAG-3 antibody  tumor immunotherapy  antibody-drug combination
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号